首页> 外文OA文献 >Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)

【2h】

Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)

机译：目前双抗CTLA4和PD-1 / PD-L1癌症免疫疗法的景观与未来;与黑色素瘤和非小细胞肺癌（NSCLC）的临床试验学习的经验教训

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Young Kwang Chae; Ayush Arya; Wade Iams; Marcelo R. Cruz; Sunandana Chandra; Jaehyuk Choi; Francis Giles;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy [J] . Wu Si-Pei, Liao Ri-Qiang, Tu Hai-Yan, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第4期

机译：基质PD-L1阳性调节性T细胞和PD-1阳性CD8阳性T细胞定义了非小细胞肺癌不同亚群的响应至PD-1 / PD-L1阻断免疫疗法
2. Innovative immunotherapy targeting at PD-1/PD-L1 signaling pathway: mechanism, efficacy and safety analysis of monotherapy and combination therapies in non-small cell lung cancer (NSCLC) treatment [J] . Zhixuan Song, Yimiao Lin E3S Web of Conferences . 2021,第a期

机译：靶向PD-1 / PD-L1信号通路的创新免疫疗法：非小细胞肺癌（NSCLC）治疗中单药治疗和组合疗法的机制，疗效和安全分析
3. PD-1(+) natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockade [J] . Trefny Marcel P., Kaiser Monika, Stanczak Michal A., Cancer immunology, immunotherapy : . 2020,第8期

机译：PD-1 / PD-L1阻断，人非小细胞肺癌中的PD-1（+）天然杀伤细胞可以通过PD-1 / PD-L1封闭来激活
4. Enumeration and ALK Investigation of Circulating Tumor Cells in Non-Small Cell Lung Cancer (NSCLC) Patients Using an Effective In Vivo Technology, the GILUPI CellCollector? [C] . Klaus Luecke, Lukasz Gasiorowski, Stefanie Herold, International Molecular Medicine Tri-Conference. . 2015

机译：使用有效的体内技术（Gilupi Cellcollector
5. Pre-Treatment Radiomics Models for Clinical Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC) [D] . Shaffer, Nathan Allen. 2021

机译：早期非小细胞肺癌临床结果的预处理辐射瘤模型（NSCLC）
6. Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC) [O] . Young Kwang Chae, Ayush Arya, Wade Iams, 2018

机译：抗CTLA4和PD-1 / PD-L1双重阻断免疫疗法在癌症中的现状和未来；从黑色素瘤和非小细胞肺癌（NSCLC）的临床试验中学到的经验教训
7. Clinical Efficacy of Immunotherapy with Pd-1/Pd-L1 Inhibitors for the Treatment of Advanced Non-Small Cell Lung Cancer [O] . 2020

机译：PD-1 / Pd-L1抑制剂治疗晚期非小细胞肺癌的临床疗效

Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)

著录项

引文网络

相似文献

相关主题

期刊订阅